GH-axis / body composition
CJC-1295 + Ipamorelin
CJC-1295 and ipamorelin each have human endocrine/PK evidence, but that does not establish additive benefit, an optimal ratio or long-term safety for the.
Exact-combination evidence
Community-popular combination; component evidence only
CJC-1295 and ipamorelin each have human endocrine/PK evidence, but that does not establish additive benefit, an optimal ratio or long-term safety for the combination.
Human combination evidence
No direct controlled human combination trial identified in current evidence set
Combination safety
No validated combination safety framework